Clinuvel Pharmaceuticals (ASX:CUV) has reported encouraging preliminary results from its second study of afamelanotide in ...

Aster MIMS achieves Comprehensive Stroke Center accreditation from the American Heart Association, enhancing advanced stroke ...

Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.

For patients with ischemic stroke, tenecteplase seems to be a reasonable alternative to alteplase in terms of effecti ...

Acute ischemic stroke, which occurs due to a blockage in cerebral blood flow, requires prompt intervention with thrombolytic ...

The usage of tenecteplase in patients with acute ischemic stroke was associated with similar effectiveness and safety ...

A woman who had a stroke and told her heart was barely working, started swimming in a bid to get better after the life ...

A new meta-analysis examines the effects of dual antiplatelet therapy after thrombolysis in minor stroke patients. Findings ...

Hospitals serving disadvantaged communities are less likely to administer IV thrombolysis for stroke, compared with hospitals in more affluent areas, a new study suggests.

THE Nigerian Society of Neurological Sciences (NSNS) says diabetes and hypertension are frequently the most prevalent risk factors for stroke, and the country still has a significant burden of stroke ...

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2024 Conference Call.

The analysis found that early support discharge took place among just nine per cent of stroke patients here in 2023. This is ...